1. Home
  2. AUID vs ITRM Comparison

AUID vs ITRM Comparison

Compare AUID & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$1.82

Market Cap

25.8M

Sector

Technology

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.15

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUID
ITRM
Founded
2009
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.8M
24.3M
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
AUID
ITRM
Price
$1.82
$0.15
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
387.9K
659.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
60.00
57.43
EPS
N/A
N/A
Revenue
$886,485.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$947.65
P/E Ratio
N/A
N/A
Revenue Growth
365.86
N/A
52 Week Low
$0.84
$0.20
52 Week High
$9.44
$1.49

Technical Indicators

Market Signals
Indicator
AUID
ITRM
Relative Strength Index (RSI) 59.10 31.75
Support Level $1.19 N/A
Resistance Level $1.94 $0.39
Average True Range (ATR) 0.18 0.04
MACD 0.00 -0.00
Stochastic Oscillator 98.35 7.85

Price Performance

Historical Comparison
AUID
ITRM

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring cyber-savvy enterprises Know Who's Behind the Device, for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric password less authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: